Aberrant cerebrovascular reactivity presents as an early biomarker of psychosis susceptibility in patients with 22q11.2DS
Farnaz Delavari, Stefano Moia, Silas Forrer, Corrado Sandini, Nada Kojovic, Alessandro Pascucci, Clémence Lacour, Stephan Eliez M. D, Dimitri Van De Ville
This study identifies early cerebrovascular reactivity impairments in 22q11.2DS as a biomarker for psychosis susceptibility, particularly in regions like the anterior cingulate cortex and globi pallidi.
Translational Psychiatry · Aug 14, 2026Peer-reviewedNeuroscience